These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23178962)

  • 1. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
    Zhang L; Chen X; Liu J; Zhu Q; Leng Y; Luo X; Jiang H; Liu H
    Eur J Med Chem; 2012 Dec; 58():624-39. PubMed ID: 23178962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.
    Zhang L; Li H; Zhu Q; Liu J; Chen L; Leng Y; Jiang H; Liu H
    Bioorg Med Chem; 2009 Oct; 17(20):7301-12. PubMed ID: 19758809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
    Feuillastre S; Chajistamatiou AS; Potamitis C; Zervou M; Zoumpoulakis P; Chrysina ED; Praly JP; Vidal S
    Bioorg Med Chem; 2012 Sep; 20(18):5592-9. PubMed ID: 22910227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z; Németi B
    Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.
    Zhang L; Chen J; Gong Y; Liu J; Zhang L; Hua W; Sun H
    Chem Biodivers; 2009 Jun; 6(6):864-74. PubMed ID: 19551727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
    Varga G; Docsa T; Gergely P; Juhász L; Somsák L
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and activity evaluation of GK/PPARγ dual-target-directed ligands as hypoglycemic agents.
    Lu J; Lei L; Huan Y; Li Y; Zhang L; Shen Z; Hu W; Feng Z
    ChemMedChem; 2014 May; 9(5):922-7. PubMed ID: 24737574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
    Habash M; Taha MO
    Bioorg Med Chem; 2011 Aug; 19(16):4746-71. PubMed ID: 21788139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPARγ.
    Li Y; Tian K; Qin A; Zhang L; Huo L; Lei L; Shen Z; Song H; Feng Z
    Eur J Med Chem; 2014 Apr; 76():182-92. PubMed ID: 24583379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule glucokinase activators as novel anti-diabetic agents.
    Leighton B; Atkinson A; Coghlan MP
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):371-4. PubMed ID: 15787609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
    Liang Z; Zhang L; Li L; Liu J; Li H; Zhang L; Chen L; Cheng K; Zheng M; Wen X; Zhang P; Hao J; Gong Y; Zhang X; Zhu X; Chen J; Liu H; Jiang H; Luo C; Sun H
    Eur J Med Chem; 2011 Jun; 46(6):2011-21. PubMed ID: 21439694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.
    Iino T; Sasaki Y; Bamba M; Mitsuya M; Ohno A; Kamata K; Hosaka H; Maruki H; Futamura M; Yoshimoto R; Ohyama S; Sasaki K; Chiba M; Ohtake N; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5531-8. PubMed ID: 19726182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and SAR of novel glucokinase activators.
    Cheruvallath ZS; Gwaltney SL; Sabat M; Tang M; Feng J; Wang H; Miura J; Guntupalli P; Jennings A; Hosfield D; Lee B; Wu Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2166-71. PubMed ID: 23434031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.
    Sarabu R; Grimsby J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):631-7. PubMed ID: 16159025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2-(β-D-glucopyranosylamino)-5-substituted-1,3,4-oxadiazoles for inhibition of glycogen phosphorylase.
    Tóth M; Szőcs B; Kaszás T; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2013 Nov; 381():196-204. PubMed ID: 23673237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of substituted 2-(β-D-glucopyranosyl)-benzimidazoles and their evaluation as inhibitors of glycogen phosphorylase.
    Bokor É; Szilágyi E; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2013 Nov; 381():179-86. PubMed ID: 23419607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold.
    Bonn P; Brink DM; Fägerhag J; Jurva U; Robb GR; Schnecke V; Svensson Henriksson A; Waring MJ; Westerlund C
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7302-5. PubMed ID: 23149230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators.
    Iino T; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Apr; 17(7):2733-43. PubMed ID: 19282189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG; Somsák L
    Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S
    Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.